Topical 5-fluorouracil 1% for moderate to extensive ocular surface squamous neoplasia in 73 consecutive patients: Primary versus secondary treatment
Open Access
- 22 March 2024
- journal article
- research article
- Published by Elsevier in Asia-Pacific Journal of Ophthalmology
- Vol. 13 (2) , 100052
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Topical 1% 5-fluorouracil eye drops as primary treatment for ocular surface squamous neoplasia: Long-term follow-up studyThe Ocular Surface, 2022
- Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous NeoplasiaAmerican Journal of Ophthalmology, 2019
- Topical 5-Fluorouracil 1% as Primary Treatment for Ocular Surface Squamous NeoplasiaOphthalmology, 2016
- Conjunctival squamous cell neoplasia: the Liverpool Ocular Oncology Centre experienceGraefe's Archive for Clinical and Experimental Ophthalmology, 2014
- Giant Ocular Surface Squamous Neoplasia Managed with Interferon Alpha-2b as Immunotherapy or ImmunoreductionOphthalmology, 2012
- Randomized Controlled Trial of Topical Mitomycin C for Ocular Surface Squamous NeoplasiaOphthalmology, 2007
- Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumorsOphthalmology, 2004
- Surgical Management of Conjunctival TumorsArchives of Ophthalmology (1950), 1997
- Mitomycin C Therapy for Corneal Intraepithelial NeoplasiaAmerican Journal of Ophthalmology, 1994
- Topical application of 5-Fluorouracil in premalignant lesions of cornea, conjunctiva and eyelidDocumenta Ophthalmologica, 1986